Skip to main content
Erschienen in: Infection 4/2016

19.01.2016 | Original Paper

Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort

verfasst von: Emanuele Durante-Mangoni, Pia Clara Pafundi, Veronica Ravasio, Francesco Barbaro, Matteo Bassetti, Pierangelo Chinello, Marco Falcone, Maria Bruna Pasticci, Pier Giorgio Scotton, Roberto Stellini, Marie-Françoise Tripodi, Riccardo Utili, Marco Rizzi

Erschienen in: Infection | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Persons on hemodialysis (HD) are at high risk of infective endocarditis (IE). In non-comparative retrospective studies, a higher rate of mortality was reported in IE on HD. We assessed risk factors, clinical characteristics, and outcomes of IE in HD.

Methods

This was a prevalence study with a case control methodology on a set of data from the prospectively followed cohort of the Studio Endocarditi Italiano (SEI), conducted between 2004 and 2011. Included were 42 consecutive cases of IE HD subjects and 126 controls not on HD, matched for age, sex, type of IE, and heart side involved. Clinical, echocardiographic, microbiological features, and disease complications and therapeutic modalities were assessed.

Results

HD patients were more often diabetics (42.9 vs 18.2 % in no-HD; p = 0.007) and immune-suppressed (16.7 vs 3.2 %; p = 0.02), and had a higher rate of predisposing cardiac conditions (45 vs 25 %; p = 0.031). A higher prevalence of health care-related acquisition and a shorter diagnostic delay was observed in IE on HD, that was more likely to be caused by staphylococci and less by streptococci (p < 0.002). Cardiac surgery was performed in 38 % of HD patients and 36.5 % of no-HD patients (p = 0.856). Complications were similar and in-hospital mortality did not differ significantly (26.2 % in HD vs 15.9 % in no-HD; p = 0.168).

Conclusions

IE in persons on HD is characterized by distinctive clinical features, including a higher prevalence of some important comorbidities. Inconsistent with prior studies, we could not confirm a higher rate of complications and mortality in HD patients with IE.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58(4):1758–64.CrossRefPubMed Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58(4):1758–64.CrossRefPubMed
2.
Zurück zum Zitat Jager KJ, Lindholm B, Goldsmith D, et al. For EUropean REnal and CArdiovascular Medicine working group of the European Renal Association-European Dialysis and Transplant Association (ERA–EDTA). Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link? Kidney Int Suppl. 2011;1(1):21–3.CrossRef Jager KJ, Lindholm B, Goldsmith D, et al. For EUropean REnal and CArdiovascular Medicine working group of the European Renal Association-European Dialysis and Transplant Association (ERA–EDTA). Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link? Kidney Int Suppl. 2011;1(1):21–3.CrossRef
3.
Zurück zum Zitat Strom BL, Abrutyn E, Berlin JA, et al. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation. 2000;102(23):2842–8.CrossRefPubMed Strom BL, Abrutyn E, Berlin JA, et al. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation. 2000;102(23):2842–8.CrossRefPubMed
4.
Zurück zum Zitat Spies C, Madison JR, Schatz IJ. Infective endocarditis in patients with end-stage renal disease: clinical presentation and outcome. Arch Intern Med. 2004;164(1):71–5.CrossRefPubMed Spies C, Madison JR, Schatz IJ. Infective endocarditis in patients with end-stage renal disease: clinical presentation and outcome. Arch Intern Med. 2004;164(1):71–5.CrossRefPubMed
5.
Zurück zum Zitat Murdoch DR, Corey GR, Hoen B, et al. International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463–73.CrossRefPubMedPubMedCentral Murdoch DR, Corey GR, Hoen B, et al. International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463–73.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Stevenson KB, Hannah EL, Lowder CA, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002;39(3):549–55.CrossRefPubMed Stevenson KB, Hannah EL, Lowder CA, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002;39(3):549–55.CrossRefPubMed
7.
Zurück zum Zitat Wang AY, Wang M, Woo J, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol. 2003;14(1):159–68.CrossRefPubMed Wang AY, Wang M, Woo J, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol. 2003;14(1):159–68.CrossRefPubMed
8.
Zurück zum Zitat Sharma R, Pellerin D, Gaze DC, et al. Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease. Atherosclerosis. 2007;191(2):348–54.CrossRefPubMed Sharma R, Pellerin D, Gaze DC, et al. Mitral annular calcification predicts mortality and coronary artery disease in end stage renal disease. Atherosclerosis. 2007;191(2):348–54.CrossRefPubMed
9.
Zurück zum Zitat Hauser AB, Stinghen AE, Kato S, et al. Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int. 2008;28(Suppl 3):S183–7.PubMed Hauser AB, Stinghen AE, Kato S, et al. Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int. 2008;28(Suppl 3):S183–7.PubMed
10.
Zurück zum Zitat Nucifora G, Badano LP, Viale P, et al. Infective endocarditis in chronic haemodialysis patients: an increasing clinical challenge. Eur Heart J. 2007;28(19):2307–12.CrossRefPubMed Nucifora G, Badano LP, Viale P, et al. Infective endocarditis in chronic haemodialysis patients: an increasing clinical challenge. Eur Heart J. 2007;28(19):2307–12.CrossRefPubMed
11.
Zurück zum Zitat Lentino JR, Baddour LM, Wray M, Wong ES, Yu VL. Staphylococcus aureus and other bacteremias in hemodialysis patients: antibiotic therapy and surgical removal of access site. Infection. 2000;28(6):355–60.CrossRefPubMed Lentino JR, Baddour LM, Wray M, Wong ES, Yu VL. Staphylococcus aureus and other bacteremias in hemodialysis patients: antibiotic therapy and surgical removal of access site. Infection. 2000;28(6):355–60.CrossRefPubMed
12.
Zurück zum Zitat Rekik S, Trabelsi I, Hentati M, et al. Infective endocarditis in hemodialysis patients: clinical features, echocardiographic data and outcome: a 10-year descriptive analysis. Clin Exp Nephrol. 2009;13(4):350–4.CrossRefPubMed Rekik S, Trabelsi I, Hentati M, et al. Infective endocarditis in hemodialysis patients: clinical features, echocardiographic data and outcome: a 10-year descriptive analysis. Clin Exp Nephrol. 2009;13(4):350–4.CrossRefPubMed
13.
Zurück zum Zitat Maraj S, Jacobs LE, Kung SC, et al. Epidemiology and outcome of infective endocarditis in hemodialysis patients. Am J Med Sci. 2002;324(5):254–60.CrossRefPubMed Maraj S, Jacobs LE, Kung SC, et al. Epidemiology and outcome of infective endocarditis in hemodialysis patients. Am J Med Sci. 2002;324(5):254–60.CrossRefPubMed
14.
Zurück zum Zitat Nori US, Manoharan A, Thornby JI, Yee J, Parasuraman R, Ramanathan V. Mortality risk factors in chronic haemodialysis patients with infective endocarditis. Nephrol Dial Transpl. 2006;21(8):2184–90.CrossRef Nori US, Manoharan A, Thornby JI, Yee J, Parasuraman R, Ramanathan V. Mortality risk factors in chronic haemodialysis patients with infective endocarditis. Nephrol Dial Transpl. 2006;21(8):2184–90.CrossRef
15.
Zurück zum Zitat Ruiz M, Sánchez MP, Domínguez JC, et al. Infective endocarditis in patients receiving chronic hemodialysis: clinical features and outcome. J Heart Valve Dis. 2005;14(1):11–4.PubMed Ruiz M, Sánchez MP, Domínguez JC, et al. Infective endocarditis in patients receiving chronic hemodialysis: clinical features and outcome. J Heart Valve Dis. 2005;14(1):11–4.PubMed
16.
Zurück zum Zitat Doulton T, Sabharwal N, Cairns HS, et al. Infective endocarditis in dialysis patients: new challenges and old. Kidney Int. 2003;64(2):720–7.CrossRefPubMed Doulton T, Sabharwal N, Cairns HS, et al. Infective endocarditis in dialysis patients: new challenges and old. Kidney Int. 2003;64(2):720–7.CrossRefPubMed
17.
Zurück zum Zitat Shroff GR, Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients with bacterial endocarditis in the United States. Am J Kidney Dis. 2004;44(6):1077–82.CrossRefPubMed Shroff GR, Herzog CA, Ma JZ, Collins AJ. Long-term survival of dialysis patients with bacterial endocarditis in the United States. Am J Kidney Dis. 2004;44(6):1077–82.CrossRefPubMed
18.
Zurück zum Zitat Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–8.CrossRefPubMed Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633–8.CrossRefPubMed
19.
Zurück zum Zitat Leone S, Ravasio V, Durante-Mangoni E, et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection. 2012;40(5):527–35.CrossRefPubMed Leone S, Ravasio V, Durante-Mangoni E, et al. Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis. Infection. 2012;40(5):527–35.CrossRefPubMed
20.
Zurück zum Zitat Gallieni M, Saxena R, Davidson I. Dialysis access in Europe and North America: are we on the same path? Semin Interv Radiol. 2009;26(2):96–105.CrossRef Gallieni M, Saxena R, Davidson I. Dialysis access in Europe and North America: are we on the same path? Semin Interv Radiol. 2009;26(2):96–105.CrossRef
21.
Zurück zum Zitat Thakar S, Janga KC, Tolchinsky T, et al. Superior vena cava and right atrium wall infective endocarditis in patients receiving hemodialysis. Heart Lung. 2012;41(3):301–7.CrossRefPubMed Thakar S, Janga KC, Tolchinsky T, et al. Superior vena cava and right atrium wall infective endocarditis in patients receiving hemodialysis. Heart Lung. 2012;41(3):301–7.CrossRefPubMed
22.
Zurück zum Zitat Nguyen DB, Lessa FC, Belflower R, et al. Invasive methicillin-resistant Staphylococcus aureus infections among patients on chronic dialysis in the United States, 20052011. Clin Infect Dis. 2013;57(10):1393–400.CrossRefPubMedPubMedCentral Nguyen DB, Lessa FC, Belflower R, et al. Invasive methicillin-resistant Staphylococcus aureus infections among patients on chronic dialysis in the United States, 20052011. Clin Infect Dis. 2013;57(10):1393–400.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Stryjewski ME, Szczech LA, Benjamin DK Jr, et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis. 2007;44(2):190–6.CrossRefPubMed Stryjewski ME, Szczech LA, Benjamin DK Jr, et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis. 2007;44(2):190–6.CrossRefPubMed
24.
Zurück zum Zitat Lodise TP Jr, McKinnon PS, Levine DP, Rybak MJ. Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother. 2007;51(10):3731–3.CrossRefPubMedPubMedCentral Lodise TP Jr, McKinnon PS, Levine DP, Rybak MJ. Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother. 2007;51(10):3731–3.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Chu VH, Cabell CH, Benjamin DK Jr, et al. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109(14):1745–9.CrossRefPubMed Chu VH, Cabell CH, Benjamin DK Jr, et al. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109(14):1745–9.CrossRefPubMed
26.
Zurück zum Zitat Fowler VG Jr, Boucher HW, Corey GR, et al. S. aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355(7):653–65.CrossRefPubMed Fowler VG Jr, Boucher HW, Corey GR, et al. S. aureus Endocarditis and Bacteremia Study Group. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med. 2006;355(7):653–65.CrossRefPubMed
Metadaten
Titel
Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort
verfasst von
Emanuele Durante-Mangoni
Pia Clara Pafundi
Veronica Ravasio
Francesco Barbaro
Matteo Bassetti
Pierangelo Chinello
Marco Falcone
Maria Bruna Pasticci
Pier Giorgio Scotton
Roberto Stellini
Marie-Françoise Tripodi
Riccardo Utili
Marco Rizzi
Publikationsdatum
19.01.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 4/2016
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-015-0870-y

Weitere Artikel der Ausgabe 4/2016

Infection 4/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.